JP2004526758A - 紫外線ｂにより誘導される皮膚損傷の予防法 - Google Patents

紫外線ｂにより誘導される皮膚損傷の予防法 Download PDF

Info

Publication number
JP2004526758A
JP2004526758A JP2002580892A JP2002580892A JP2004526758A JP 2004526758 A JP2004526758 A JP 2004526758A JP 2002580892 A JP2002580892 A JP 2002580892A JP 2002580892 A JP2002580892 A JP 2002580892A JP 2004526758 A JP2004526758 A JP 2004526758A
Authority
JP
Japan
Prior art keywords
tsp
uvb
patient
cells
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002580892A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526758A5 (OSRAM
Inventor
ジェイ． デットマー マイケル
喜一郎 矢野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of JP2004526758A publication Critical patent/JP2004526758A/ja
Publication of JP2004526758A5 publication Critical patent/JP2004526758A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2002580892A 2001-04-13 2002-04-11 紫外線ｂにより誘導される皮膚損傷の予防法 Pending JP2004526758A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
PCT/US2002/011403 WO2002083088A1 (en) 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage

Publications (2)

Publication Number Publication Date
JP2004526758A true JP2004526758A (ja) 2004-09-02
JP2004526758A5 JP2004526758A5 (OSRAM) 2005-08-18

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002580892A Pending JP2004526758A (ja) 2001-04-13 2002-04-11 紫外線ｂにより誘導される皮膚損傷の予防法

Country Status (8)

Country Link
US (1) US6712617B2 (OSRAM)
EP (1) EP1377253A4 (OSRAM)
JP (1) JP2004526758A (OSRAM)
KR (2) KR20080108366A (OSRAM)
CN (1) CN100340287C (OSRAM)
CA (1) CA2446093A1 (OSRAM)
TW (1) TWI233361B (OSRAM)
WO (1) WO2002083088A1 (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540408A (ja) * 2005-05-05 2008-11-20 ジェネンコー・インターナショナル・インク パーソナルケア組成物及びそれらの使用方法
WO2011040496A1 (ja) 2009-09-30 2011-04-07 株式会社資生堂 ヘパラナーゼ活性阻害剤

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
JP5122060B2 (ja) * 2002-06-25 2013-01-16 株式会社 資生堂 抗老化剤
EP1541570A4 (en) * 2002-07-31 2008-05-21 Mercian Corp NEW PHYSIOLOGICALLY EFFECTIVE SUBSTANCE
WO2004011661A1 (ja) * 2002-07-31 2004-02-05 Mercian Corporation 新規生理活性物質
AU2003282683A1 (en) 2002-10-04 2004-05-04 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
NZ540103A (en) * 2002-11-29 2007-05-31 Mercian Corp Process for producing macrolide compound
WO2005097187A2 (en) * 2004-04-01 2005-10-20 The General Hospital Corporation Methods of preventing uvb-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
WO2006042114A1 (en) * 2004-10-06 2006-04-20 Cook, Inc. Emboli capturing device having a coil and method for capturing emboli
US7831890B2 (en) 2004-10-12 2010-11-09 Aware, Inc. Resource sharing in a telecommunications environment
EP2561883A3 (en) * 2005-09-16 2013-04-17 Shiseido Company, Ltd. Novel vascular endothelial growth factor expression inhibitors
ATE476986T1 (de) 2006-01-18 2010-08-15 Gen Hospital Corp Verfahren zur steigerung der lymphatischen funktion
US8335956B2 (en) 2006-04-12 2012-12-18 Tq Delta, Llc Packet retransmission and memory sharing
WO2008005533A2 (en) * 2006-07-06 2008-01-10 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
AU2007285215A1 (en) * 2006-08-14 2008-02-21 Eisai R & D Management Co., Ltd. Stable lyophilized preparation
MX2009008068A (es) * 2007-01-29 2009-11-18 Eisai R&D Man Co Ltd Compuesto macrolido en forma solida, proceso para su preparacion y composicion farmaceutica que lo contiene.
KR20100065190A (ko) 2007-09-14 2010-06-15 닛토덴코 가부시키가이샤 약물 담체
US9132202B2 (en) 2009-07-17 2015-09-15 Aaron T. Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
US12358963B2 (en) 2019-12-24 2025-07-15 Juvena Therapeutics, Inc. Regenerative polypeptides and uses thereof
WO2021133858A1 (en) * 2019-12-24 2021-07-01 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
CA3223707A1 (en) 2021-06-21 2022-12-29 Hanadie Yousef Regenerative polypeptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
CN1084595C (zh) * 1997-05-27 2002-05-15 塞姆柏奥希斯遗传学公司 油体的用途
WO1999026649A1 (en) * 1997-11-25 1999-06-03 Cornell Research Foundation, Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
AU766098B2 (en) 1999-03-31 2003-10-09 General Hospital Corporation, The Thrombospondin-2 and uses thereof
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540408A (ja) * 2005-05-05 2008-11-20 ジェネンコー・インターナショナル・インク パーソナルケア組成物及びそれらの使用方法
WO2011040496A1 (ja) 2009-09-30 2011-04-07 株式会社資生堂 ヘパラナーゼ活性阻害剤
US8609075B2 (en) 2009-09-30 2013-12-17 Shiseido Company, Ltd. Heparanase activity inhibitor
US8901160B2 (en) 2009-09-30 2014-12-02 Shiseido Company, Ltd. Heparanase activity inhibitor

Also Published As

Publication number Publication date
US20030008821A1 (en) 2003-01-09
KR20040021598A (ko) 2004-03-10
KR20080108366A (ko) 2008-12-12
CN100340287C (zh) 2007-10-03
CN1512868A (zh) 2004-07-14
EP1377253A4 (en) 2008-09-03
EP1377253A1 (en) 2004-01-07
WO2002083088A1 (en) 2002-10-24
US6712617B2 (en) 2004-03-30
TWI233361B (en) 2005-06-01
CA2446093A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
US6712617B2 (en) Methods of preventing UVB-induced skin damage
JP5960749B2 (ja) 毛の成長を調節する方法
US6773881B2 (en) Methods of modulating hair growth
JP2008530003A (ja) 創傷治癒を向上させるための、および線維症予防のためのミオスタチン（ｇｄｆ−８）アンタゴニストの使用
AU2001253012A1 (en) Methods of modulating hair growth
JPH09509825A (ja) 骨細胞を刺激するための方法および組成物
Saito et al. Exploring the biology of the nail: An intriguing but less-investigated skin appendage
US9351914B2 (en) Methods for modulating hair growth using truncated laminin-511
JP2010043121A (ja) アクチン結合ペプチドを利用する髪の成長を促進する方法及び組成物
Tu et al. Cbfa1/Runx2‐deficiency delays bone wound healing and locally delivered Cbfa1/Runx2 promotes bone repair in animal models
EP2121142B1 (en) Use of gdf-5 for the improvement or maintenance of dermal appearance
KR20160035586A (ko) 치은 섬유모세포의 탈모증 치료 용도
AU2002254588B2 (en) Methods of Preventing UVB-Induced Skin Damage
WO2004006949A1 (en) Methods and compositions for regulation of mammalian hair growth
AU2002254588A1 (en) Methods of Preventing UVB-Induced Skin Damage
TWI925442B (zh) 用於治療脫髮和/或白髮的工程化外泌體及其組合物和用途
CN100551437C (zh) 附睾特异的抗菌肽Bin1b在精子成熟方面的用途
Chi et al. Epidermal growth factor expression in middle ear cholesteatoma
Jalil The Influence of Anisotropic Tissue Expander on Nestin and Trkb Expression in Rat Cranio-facial Region.
Class et al. Patent application title: Methods for Modulating Hair Growth Using Truncated Laminin-511 Inventors: M. Peter Marinkovich (Redwood City, CA, US) Jing Gao (Mountain View, CA, US) Xiaoyu Xu (Foster City, CA, US) Jayakumar Rajadas (Cupertino, CA, US) Jayakumar Rajadas (Cupertino, CA, US)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050407

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080616

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080916

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080916

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090303

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090728